Bujkiewicz S
No ORCID on file
· 1 paper in corpus
· active 2025
BackgroundMulti-indication cancer drugs receive licensing extensions to include additional indications, as trial evidence on treatment effectiveness accumulates. We investigate how sharing information across indications can strengthen the i…